Expanding the DNA alphabet: ‘extra’ DNA base found to be stable
A rare DNA base, previously thought to be a temporary modification, has been shown to be stable in mammalian DNA, suggesting that it plays a key role in cellular function.
Researchers from the University of Cambridge and the Babraham Institute have found that a naturally occurring modified DNA base appears to be stably incorporated in the DNA of many mammalian tissues, possibly representing an expansion of the functional DNA alphabet.
The new study, published today in the journal Nature Chemical Biology, has found that this rare ‘extra’ base, known as 5-formylcytosine (5fC) is stable in living mouse tissues. While its exact function is yet to be determined, 5fC’s physical position in the genome makes it likely that it plays a key role in gene activity.
“If 5fC is present in the DNA of all tissues, it is probably there for a reason,” said Professor Shankar Balasubramanian of the Department of Chemistry and the Cancer Research UK Cambridge Institute, who led the research. “It had been thought this modification was solely a short-lived intermediate, but the fact that we’ve demonstrated it can be stable in living tissue shows that it could regulate gene expression and potentially signal other events in cells.”
Related News
See all news-
In Memoriam: Professor Greg Hannon (1964–2026)
9th April 2026
It is with profound sadness that we share the news of the passing of Professor Greg Hannon, who led the Cancer Research UK Cambridge Institute for over eight years.
Find out more -
Most detailed map of breast tissue changes reveals role of menopause in cancer susceptibility
31st March 2026
Scientists have created the most detailed map to date, comprising over 3 million cells, showing how breast tissue changes as women age – including dramatic changes during menopause.
Find out more -
Hannon Group joins global team to decode cancer’s dark proteome
4th March 2026
Prof Greg Hannon and his group joins global Cancer Grand Challenges team taking on the dark proteome challenge.
Find out more